The
global critical care diagnostics market is expected to
reach USD 1.29 billion by 2024, according to a new report by Grand View
Research, Inc. The critical care diagnostics market is expected to grow at a
lucrative rate in the next few years. The key factors supporting the industry’s
growth comprise the rapid awareness and acknowledgment of these tests by
physicians and patients, the rise in geriatric population and chronic health
conditions, the employment of telehealth services in remote areas, and
technological advancements. The increased cost of the molecular diagnostics and
dearth of skilled labor are factors that are expected to hinder the growth of
the industry.
The
critical care diagnostics market by test type is categorized into routine and
special chemistry, flow cytometry, hematology, immunoproteins, microbial and
infectious diseases, coagulation testing, and others. The microbial and
infectious diseases test diagnostics segment is projected to grow at the
highest rate with a CAGR of over 5% during the forecast period. For example,
healthcare systems spend a substantial amount of resources in the collection
and processing of blood cultures for the identification of pathogens.
Critical
care diagnostic tests, such as the nucleic acid amplification test, allow
clinicians to detect and identify organisms more rapidly and accurately and
provide guidance to clinicians, who aspire to commence the appropriate
antimicrobial therapy as fast as possible and terminate the use of avoidable
drugs. The critical care diagnostic market by the end-user is categorized into
operation rooms, emergency rooms, and ICU’s. The emergency rooms segment in the
industry is anticipated to witness the highest growth rate during the forecast
period.
Full Research Report On Critical Care Diagnostics Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/critical-care-diagnostics-market
Further key
findings from the study suggest:
- The Asia Pacific region is
estimated to dominate the critical care market in terms of the highest
growth rate, with a CAGR of around 9.1% during the forecast period. The
large presence of geriatric population, increasing prevalence of chronic
diseases, increase in the number of specialty hospitals in the Asia
Pacific region, and improving healthcare services and infrastructures in
rural areas are the factors fueling the market growth.
- The immunoproteins
diagnostic test segment is estimated to account for the largest share of
the critical care diagnostic market by type. The rise in demand for rapid
and accurate preventive healthcare services is one of the major factors
driving this market growth.
- On the basis of end-users,
approximately 20% of acute-care patients get admitted into ICU’s, whereas
nearly 58% get admitted into emergency rooms. The emergency rooms are
expected to witness exponential growth with the highest CAGR during the
forecast period. The recent rise in the patient demand for ER services is
due to its ability to provide initial acute care diagnosis and treatment
of critically ill patients.
- Some major players in this
industry include Abbott., Alere, Inc., Beckman-Coulter, Roche Diagnostics,
and Becton Dickinson & Co., among others.
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/critical-care-diagnostics-market/request/rs1
Grand View Research has segmented
the global critical care diagnostics market on the basis of test type,
end-user, and region:
Global Critical
Care Diagnostics Type Outlook (Revenue, USD Million, 2013 - 2024)
- Routine and special
chemistry
- Flow cytometry
- Hematology
- Immunoproteins
- Microbial and infectious
diseases
- Coagulation test
- Others
Global Critical
Care Diagnostics End-user Outlook (Revenue, USD Million, 2013 - 2024)
- Operating rooms
- Emergency rooms
- Intensive care units
- Others
Critical Care
Diagnostics Regional Outlook (Revenue, USD Million, 2013 - 2024)
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia Pacific
- China
- India
- Latin America
- Mexico
- Brazil
- Middle East and Africa
- South Africa
- Saudi Arabia
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment